Speaker illustration

Professor Jemma C Hopewell

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Heart Failure in Atrial Fibrillation

Session type: Moderated ePosters

Thumbnail

Risk factors for cognitive impairment in atrial fibrillation patients

Event: ESC Congress 2023

Topic: Cognitive Function and Autonomy in Patients with Atrial Fibrillation

Session type: Moderated ePosters

Thumbnail

Risks and screening for atrial fibrillation

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Atrial fibrillation and stroke: role of kidney disease and biomarkers

Event: ESC Congress 2023

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Thumbnail

Risk factors and prevention - Epidemiology 2

Event: ESC Congress 2022

Topic: Epidemiology

Session type: Moderated ePosters

Thumbnail

Coronary artery disease - Epidemiology, prognosis, outcome 6

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Coronary artery disease - Epidemiology, prognosis, outcome 7

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Meet the trialist - Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease

Event: ESC Congress 2019

Topic: Epidemiology

Session type: Late-Breaking Science

Thumbnail

Translating new pharmacology science into clinical practice

Event: ESC Congress 2019

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb